Remedium Lifecare Limited Charts Long-Term Growth with Global Subsidiary, Export Contract and Strong Investor Support
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Supha Pharmachem Ltd on 6ix
Earlier from Supha Pharmachem
- Supha Pharmachem Ltd Press Release Jul 14 2025
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Supha Pharmachem Ltd Press Release Jul 11 2025
- Submission Of Newspaper For Postal Ballot Notice
- Supha Pharmachem Ltd Press Release Jul 10 2025
Later from Supha Pharmachem
- Board Meeting Intimation for Meeting Scheduled To Be Held On 04.08.2025
- Supha Pharmachem Ltd Press Release Jul 30 2025
- Board Meeting Outcome for Board Meeting Outcome For The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended June 30, 2025
- Results For The Quarter Ended June 30, 2025.
- Supha Pharmachem Ltd Press Release Aug 04 2025
Follow Supha Pharmachem into a list and get an email when it puts out news.
Follow Supha Pharmachem